ASND compared with CYTK: revenue, margins and what each company keeps, and the suppliers and customers both name

ASNDAscendis Pharma A/S

Mkt capRevenueRevenue

CYTKCytokinetics Inc

Mkt capRevenueRevenue

Compare

ASNDAscendis Pharma A/S

CYTKCytokinetics Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ASND 3

NVONovo Nordisk A/Scustomer

—Teijinunlistedcustomer

—VISEN Pharmaceuticalsunlistedcustomer

Shared 0

No shared counterparties.

Only CYTK 6

AMGNAmgencustomer

KRCKilroy Realtysupplier

SNYSanoficustomer

—Royalty Pharma Investments 2019 ICAVunlisted

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

supplier

2 more · CYTK chain ›

ASNDAscendis Pharma A/S

249.90▲+0.37%

Mkt cap$15.6BRevenue—Revenue—

CYTKCytokinetics Inc

62.66▲+1.01%

Regular sessionNov 3 '26

Mkt cap$8.8BRevenue$29MQ2 FY26Revenue$88MFY25

Compare

Regular sessionNov 3 '26

ASNDAscendis Pharma A/S

CYTKCytokinetics Inc

249.90▲+0.37%

Price

62.66▲+1.01%

$15.6B

Mkt cap

$8.8B

—

Revenue

$29MQ2 FY26

—

Revenue

$88MFY25

ASND249.90▲+0.37%vsCYTK62.66▲+1.01%Regular sessionNov 3 '26